Oncology
5,778 studies502 in 7 days2,682 in 30 days
Filters
Latest
5,778 studies
- FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapy
- Cuproptosis in glioma: mechanisms, biological roles and therapeutic perspectives
- Primary hepatic adenosquamous carcinoma and proteomic analysis: a case report
- Targeting cancer stem cells: advances in small molecules, biologics, and immunotherapies
- Association of neoadjuvant therapy with locoregional recurrence according to recurrence definitions in breast cancer: a retrospective cohort study
- Non-invasive diagnostic evaluation of urinary exosomal let-7c cluster expression in bladder cancer using machine learning approaches
- A disease-specific immunonutritional model for prognostic stratification in oral cavity squamous cell carcinoma
- Ion homeostasis related gene signature characterizes the immune landscape and predicts prognosis in lung adenocarcinoma
- Inhibition of the ATR-CHK1 signaling pathway sensitizes MCPyV-positive Merkel cell carcinoma to gemcitabine
- Anethole suppresses proliferation and migration of lung adenocarcinoma cells and modulates ESRβ/SRC/EGFR-related signaling
- Regional divergence in female cancer mortality in Brazil signals the unequal pace of the cancer transition
- Serglycin-ROS axis mediates synergistic lethality of PI3Kγ inhibition and Azacitidine in TP53-mutated AML
- Efficacy and safety of cetuximab-irinotecan rechallenge versus regorafenib in ras wild-type metastatic colorectal cancer: a single-center exploratory randomized trial
- A single-cell derived immune risk score predicts recurrence in NSCLC following neoadjuvant chemo-immunotherapy
- TIRELESS study protocol: non-inferiority study of nurse-led web-based cognitive behavioral therapy for cancer-related fatigue in patients with incurable cancer
- Therapeutic targeting of CD47 using a tri-specific NK cell engager to inhibit multiple myeloma
- Validation and prognostic utility of the mSMART 4.0 risk stratification system in Chinese patients with multiple myeloma
- Dosimetric superiority of proton radiosurgery in liver cancer: an in silico comparative dosimetric study
- TNFR2-targeted nanoparticles for regulatory T-cell modulation in cancer immunotherapy: a narrative review
- Reduced-dose nanoparticle albumin-bound-paclitaxel combined with ramucirumab as second-line treatment for advanced gastric cancer: a multicenter phase II study
- Nonlinear association between baseline albumin-to-alkaline phosphatase ratio and overall survival in advanced NSCLC treated with anlotinib: a two-center retrospective cohort study
- Multi-omics profiling highlights RPLP0 as a potential biomarker for prognosis and response to immunotherapy in clear cell renal cell carcinoma
- Researching the role of ubiquitination and macrophage activation-related genes in hepatocellular carcinoma through a systematic study based on gene expression profiling
- The impact of STAS on recurrence-free and overall survival in T1-2N0 adenocarcinomas: a single-center retrospective study
- Durvalumab completion and re-administration after grade 2 radiation pneumonitis following concurrent chemoradiotherapy for unresectable stage III NSCLC: a single-center real-world study